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with lower and Hispanic ethnicity with higher ALD rate only among the disabled 
born 1945-65 but not other cohorts. CONCLUSIONS: ALD prevalence patterns were 
complex and were modified by race, elderly/disability status, and the extent of 
health care access and screening capacity in the county of residence. These study 
results help inform treatment strategies for HCV in the context of coordinated 
models of care.
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OBJECTIVES: This study aimed to examine whether phototherapy (ultraviolet light 
B) can lower the risk of fractures in vitiligo patients over middle age. METHODS: 
Using the 2000-2010 Taiwan’s National Health Insurance research database, we 
identified patients with newly diagnosed vitiligo between 2003 and 2009 at age 40 
years or older. Following the diagnosis, the patients were entered into three cohorts, 
based on the frequency of phototherapy they received. The patients who received 
phototherapy equal or more than 12 times yearly were grouped into “frequent 
phototherapy cohort”; those who received phototherapy between 1 and 12 times 
yearly, “infrequent phototherapy cohort”; those who received no phototherapy, 
“phototherapy unreceived cohort”. The patients were followed until the first hip or 
vertebral fracture, death, or 31 December 2010. Cox regression models were used 
for analysis. Further analyses stratified by age and sex were carried out. RESULTS: 
We identified 3,863 patients with newly-onset vitiligo over middle age (mean age: 
57). Among these patients, 747 (19.3%) received phototherapy equal or more than 
12 times yearly, 712 (18.4%) received phototherapy between 1 and 12 times yearly, 
and 2,404 (62.2%) received no phototherapy. The frequent phototherapy cohort had 
an insignificant lower risk of fracture than the phototherapy unreceived cohort 
(adjusted hazard ratio (aHR) = 0.57, 95%CI = 0.29-1.10, p = 0.095), while the infre-
quent phototherapy cohort had a similar risk of fracture compared with the photo-
therapy unreceived cohort (aHR = 0.91, 95%CI = 0.51-1.61, p = 0.738). The stratified 
analyses showed that the patients aged 40~64 years in the frequent phototherapy 
cohort had a lower risk of fracture than those in the phototherapy unreceived cohort 
(aHR = 0.28, 95%CI = 0.10-0.79, p = 0.016). CONCLUSIONS: This study suggested 
that a frequent use of phototherapy might reduce the fracture risks among vitiligo 
patients at middle-age.
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OBJECTIVES: Remote monitoring strategies (RM) have the potential to deliver spe-
cialised care and management to patients with stable heart failure (HF). This review 
sought to determine whether RM improves outcomes for adults with stable HF 
(defined as having no acute event or deterioration in the past 28 days) who are man-
aged in the community (ambulatory or outpatient care setting). METHODS: Fourteen 
electronic databases covering the biomedical, scientific and grey literature were 
searched to November 2013, and supplemented by hand-searching relevant articles. 
Two reviewers independently extracted all relevant data. All randomised controlled 
trials (RCTs) were included. RM interventions included home telemonitoring (TM) 
with medical support provided during office hours or 24/7 and structured telephone 
support (STS) programmes delivered via human-to-human contact (HH) or human-to-
machine (voice-activated) interface (HM). RESULTS: Eighteen RCTs were included in 
the systematic review. Compared with usual care, the network meta-analysis showed 
that RM was beneficial in reducing all-cause mortality for STS HH (Hazard Ratio, HR: 
0.87, 95% Credible Interval, CrI: 0.66, 1.15), TM during office hours (HR: 0.81, 95% CrI: 
0.57, 1.16) and TM 24/7 (HR: 0.85, 95% CrI: 0.57, 1.26); however, these were statistically 
inconclusive. No favourable effect on mortality was observed with STS HM. Similarly, 
trends in reducing HF-related hospitalisations were also observed for all RM interven-
tions. CONCLUSIONS: STS HH and TM with medical support provided during office 
hours or 24/7 showed beneficial trends, particularly in reducing all-cause mortality 
for patients with stable HF. However, due to the complex nature of RM interven-
tions (including between study heterogeneity within each category), further research 
should seek to examine the ‘active ingredients’ of RM strategies including suitability 
of different systems and qualitative research (patient, partners or carers’ experiences) 
to understand the processes by which RM works.
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OBJECTIVES: The WHO has been proposing and updating a working definition of 
dengue since 1974. This definition can aid clinical prediction of severe outcomes 
and triage. Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS) 
were defined in a 1997 report. Several issues were identified with the 1997 clas-
sification, as the need for a new definition that adequately and earlier the clinical 
spectrum of the disease. In 2009, WHO release a new classification. The objective 
was to assess 1997 and 2009 WHO classifications of severe dengue. METHODS: 
A retrospective cohort study was carried out in a pediatric university hospital in 
Cartagena, Colombia. Consecutive patients admitted to the emergency department 
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OBJECTIVES: To characterize the frequency, cost, and hospital-reported out-
comes of cachexia and debility in children with complex chronic conditions 
(CCCC). METHODS: We analyzed data from the 2003-2012 data releases of the Kids’ 
Inpatient Database (Healthcare Cost & Utilization Project, Agency for Healthcare 
Research & Quality), utilizing International Classification of Diseases, 9th Revision 
(ICD-9) diagnosis codes to identify cases. We compared patient and hospitaliza-
tion characteristics for CCCC with and without cachexia (ICD-9 799.4) and debility 
(ICD-9 799.3). We examined factors which predict odds of inpatient mortality in 
CCCC using a logistic regression model and factors which impact length of stay and 
cost in CCCC using negative binomial regression models. All costs are reported in 
2014 dollars, using the Consumer Price Index inflation adjustment. RESULTS: We 
estimated hospitalization incidence of cachexia in CCCC at 1,395 discharges during 
the sample period, which increased from 277 discharges in 2003 to 473 discharges in 
2012, 421 discharges which included debility, which increased from 39 discharges in 
2003 to 217 discharges in 2012. During the sample period, 5.73% and 2.44% of CCCC 
with cachexia and debility, respectively, died during their hospital stay. Cachexia 
was associated with a 59% increase in odds of inpatient mortality while debil-
ity was associated with a 41% decrease in odds of mortality. Both cachexia and 
debility increased hospital length of stay (15% and 31% longer stays, respectively). 
The median cost of hospitalization was $15,441.59 and $23,796.16 for children with 
cachexia and debility, respectively. CONCLUSIONS: The frequency of hospitaliza-
tion for cachexia in CCCC is less than that for adults; however, the frequencies of 
cachexia diagnoses are increasing over time. Estimates of the incidence of hospitali-
zation with debility in CCCC have not been previously reported in the literature, but 
our study demonstrates that the frequency of these discharges is also increasing.
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OBJECTIVES: To identify patient-level and hospital-level factors associated with 
inpatient mortality in a cohort of ischemic stroke patients. METHODS: The 2012 U.S. 
Nationwide Inpatient Sample was used to identify patients with a primary diagnosis 
for ischemic stroke (ICD-9: 433,434,436) in the South Region. Backward selection 
technique with logistic regression was performed to identify unique patient-level 
and hospital-level factors associated with inpatient mortality. The multivariable 
analysis included hospitals with more than 30 stroke cases in the southern region 
of the U.S. RESULTS: There were 19,071 hospitalizations for stroke in 320 hospitals 
in the South Region. The patient-level variables associated with an increased risk 
of inpatient mortality were age> 65, female gender, being white, expected primary 
payer Medicaid, private or other, score for risk of mortality, number of procedures, 
and having comorbidity of paralysis. On the other hand, number of chronic condi-
tions, having major operating room procedure, AIDS, anemia, chronic pulmonary 
disease, diabetes with chronic complications, peripheral vascular disorder, or val-
vular disease were found to be associated with lower risk of mortality. Additionally, 
interaction terms involving age, number of procedures, race, risk of mortality score 
and expected payer were found to be significant predictors. As for hospital-level 
risk factor, urban-teaching [OR= 0.51(p= 0.001)] and urban-non-teaching [OR= 0.52 
(p= 0.003)] hospitals were associated with lower mortality risk as compared to any 
rural hospitals. CONCLUSIONS: Both patient-level and hospital level factors play an 
important role in influencing in-hospital mortality of stroke patients thus under-
scoring the need to better understand the causes of death after stroke in order to 
develop strategies to improve outcomes. Close examination of reasons for relatively 
poor performance of rural hospitals in inpatient mortality of stroke patients requires 
future studies.
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OBJECTIVES: We examined patient and county-level characteristics associated 
with advanced liver disease (ALD) at hepatitis C (HCV) diagnosis in three Medicare 
cohorts: 1) elderly born before 1945; 2) disabled born 1945-1965; 3) disabled born after 
1965. METHODS: Data source was Medicare claims (2006-2009) linked to the Area 
Health Resource Files. ALD was measured over the period of 6 months before to 3 
months after diagnosis. Using weighted multivariate modified Poisson regressions 
to address generalizability of findings to all Medicare HCV patients, we modelled 
the association between contextual characteristics and the presence of ALD at HCV 
diagnosis. RESULTS: We identified 1746, 3351, 592 patients with ALD rates of 28.0%, 
23.0%, and 15.0% for birth cohorts 1), 2), 3). The prevalence of drug abuse increased 
among younger birth cohorts: 4.2%, 22.6%, and 35.6%, respectively. HIV co-infection 
(RR= 0.63, p= 0.001), dual Medicare/Medicaid eligibility (RR= 0.89, p= 0.017), residence 
in counties with higher median household income (RR range 0.82-0.86, p= 0.009-
0.065), higher density of primary care providers (RR range 0.84-0.86, p= 0.022-0.041), 
and more rural health clinics (RR= 0.90, p= 0.084) were associated with lower ALD 
rates. End stage renal disease (RR= 1.41, p= 0.001), alcohol abuse (RR= 2.57, p= 0.001), 
hepatitis B co-infection (RR= 1.32, p= 0.004), and residence in the Midwest (RR= 1.22, 
p= 0.010) were associated with higher ALD rates. Living in rural counties with high 
screening capacity was protective in the elderly but associated with higher ALD rates 
among the disabled born 1945-65. Compared to Whites, Black race was associated 
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as not exposed to allopurinol for 121 days (which contains 30 days grace period 
for refilling and 91 days for washout RESULTS: In multivariable-adjusted that 
adjusted for all factors except medication and disease severity factors (model 5), 
we found that the following factors were significantly associated with higher odds 
of allopurinol MPR ≥ 80%: older age, Caucasian race, being currently married; gout 
care from primary care provider specialty, smaller facility bed size, community-
based outpatient clinic and Midwest location; means test, service connection ≥ 50% 
and longer distance to the nearest VA. Higher BMI had a non-significant trend 
towards higher odds of allopurinol MPR ≥ 80%. CONCLUSIONS: In this study, we 
identified several novel factors associated with allopurinol adherence. This new 
knowledge can be used to improve the likelihood of success of lowering serum 
urate with allopurinol pharmacotherapy by targeting modifiable risk factors iden-
tified in our study.
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OBJECTIVES: To compare the effect on metabolic control between conventional 
and analogues insulins. METHODS: Retrospective cohort study in primary care 
centers in cities of Pereira and Manizales from Colombia. Monitoring period 
18 months to patients diagnosed with diabetes mellitus type 1 and 2 selected 
by stratified random sampling, of pay regime members of the Health System 
of Colombia, treated with conventional and analogues insulins (glargine, gluli-
sine, aspartate, detemir) for at least 6 months. Collecting data from the clinical 
records and analytical results for each patient. Comparison groups according to 
the type of insulin received were created (insulin glargine vs NPH; NPH / glargine 
vs regular / glulisine). Primary and secondary variables: initial HbA1c measure-
ment and comparison at 6 months and 3 and 18 months respectively. RESULTS: 
313 patients were included with a mean age of 57.3 years and 56.9% were female. 
No statistically significant difference in reducing glycosylated hemoglobin at 3, 
6 and 18 months comparing groups insulin glargine vs NPH (p = 0.403) and NPH/
glargine vs regular/glulisine (p = 0.514) were observed. The percentage of patients 
with metabolic control increased from 27.8% to 34.2% during follow-up with all 
insulins. CONCLUSIONS: We did not find that analogue insulins were superior to 
human in glycemic control effect and a high percentage of patients did not meet 
the recommended treatment, which requires implement measures to improve the 
monitoring and control of diabetes mellitus.
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OBJECTIVES: To understand NHS hospital activity associated with Tuberous 
Sclerosis Complex (TSC) management, and support the development of specialised 
commissioned services in England. METHODS: Hospital Episode Statistics (HES) 
data for patients with TSC (ICD-10 code Q85.1, recorded between 2006-2013) were 
extracted in July 2014. Hospital visits and admissions occurring in 2013 were ana-
lysed nationally, at 14 ‘hub’ hospitals and at the top-five most frequently accessed 
‘spoke’ hospitals. RESULTS: Since 2006, 1922 patients were coded with TSC; age 
distribution 46% < 18 years, 54% > 18 years. In 2013 the most common TSC-associated 
conditions were epilepsy (n= 1101), developmental disorder (n= 485), benign lipo-
matous neoplasms (n= 160), childhood autism (n= 141), other convulsions (n= 60). 
615 patients attended for outpatient appointments in 2013 (all indications). There 
were 0.8 elective and 1.9 non-elective admissions/patient (n= 489 and 1180/615, 
respectively). Elective admissions averaged 3.9 bed-days per patient, with 4.2 bed-
days/admission for non-elective admissions. There were 1.9 day-case (1193/615) 
and 9.6 outpatient (5899/615) visits/patient. Of 5899 outpatient attendances, the 
top five specialties were paediatrics (17%), paediatric neurology (9%), neurology (6%) 
nephrology (5%) and ophthalmology (5%). In the ‘hub’ hospitals there were 5.4 out-
patient visits/patient, with the top five specialties being paediatric neurology (12%), 
paediatrics (6%), nephrology (6%), neurology (4%), paediatric nephrology (4% In the 
spoke providers, the top-five outpatient specialties (n= 1564 visits) were paediatrics 
(21%), learning disability (11%), neurology (8%), paediatric neurology (7%) and oph-
thalmology (6%). CONCLUSIONS: The prevalence of TSC was lower than expected, 
possibly an artefact of inappropriate NHS coding. TSC management is intensive 
with many outpatient/day-case visits, and non-elective admissions. Patients are 
also likely to be receiving care in the community, in addition to the hospital activ-
ity reported. TSC management is unevenly distributed between ‘hub’ and ‘spoke’ 
hospitals. Differentiated paediatric and adult services are needed. Fragmentation 
of TSC service provision suggests specialist management is needed, with coordina-
tion by specialist providers.
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OBJECTIVES: Worldwide, cigarette Smoking is responsible for more than 5 million 
deaths and is expected to exceed 8 million by 2030. The objective of this study was 
to identify predictors of smoking in China India and Taiwan. METHODS: A cross-
sectional study was conducted in convenient sample of adults using a pretested and 
validated questionnaire between 2008-2011 in China, India and Taiwan. Smoking 
status was ascertained among participants through one question inquiring if they 
had smoked cigarette within last 30days. RESULTS: A total of 2397 questionnaires 
(ED) from January 2013 to August 2014 with confirmed dengue test. Analyses were 
made in three steps: results description; agreement analysis with Kappa test; and 
several regression analyses. Outcome (severe dengue) was defined as critical care 
entrance. RESULTS: 761 children with confirmed dengue were analyzed. 50.6% were 
male, 67.2% stayed more than one day in the hospital. Median age was 7.9 years (IQR, 
5.0-10.7). Kappa statistics between the two definitions for hospitalized patients (n 
= 504) was 0.30 (standard error= 0.04). 137 (18%) patients were admitted with DHF/
DSS, according to WHO 1997. DHF/DSS had a sensitivity of 33.3% (95% CI, 30.0-36.7) 
and specificity of 83.2% (95% CI, 80.5-85.8) in inpatient with severe dengue. Adjusted 
binomial regression showed a relative risk of 2.3 (95% CI, 1.3-3.9) for the outcome 
in patients with DHF/DSS. WHO 2009 definition showed a sensitivity of 31.5% (95% 
CI, 28.2-34.8) and specificity of 94.3% (95% CI, 92.7-96.0). Median number of warn-
ing sign at emergency admission was 2 (IQR, 1-2). Number of warning signs was 
significantly different between patients who entered critical care versus patients 
who did not (P< 0.001). CONCLUSIONS: The WHO 2009 showed significant over-
perfomance compared WHO 1997.
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OBJECTIVES: Medication adherence among hypertensive patients is poor stemming 
from various factors. The aim of this review was to appraise published randomized 
control trials (RCTs) on hypertensive patients to determine the effectiveness of a 
pharmacist led intervention for improving medication adherence and blood pres-
sure control. METHODS: Only English language RCTs published between January 
1st, 1995 and December 31st, 2013 were considered for inclusion. Electronic data-
bases searched included: PubMed, Web of Science, Elsevier, CINAHL, and Google 
Scholar. Studies were eligible if they comprised a separate group of controls. The 
intervention, pharmaceutical care or counseling provided by a pharmacist, had 
to be compared with the usual treatment for hypertension or a combination of 
usual treatment and sham interventions. Only studies that compared outcomes 
after at least a six month follow up period using at least one or a combination of 
the following for assessing adherence: pill count, medication refill rate, or a vali-
dated adherence scale were included. RESULTS: Of 457 citations reviewed, 9 RCTs 
met the inclusion criteria. The included RCTs were conducted in various parts of 
the world, including China, Brazil, Portugal and the United States. Across the 9 
RCTs, a total of 581 individuals for the intervention group and 587 individuals in 
the control group were compared in the analyses. The outcome measures were 
systolic and diastolic blood pressure, and medication adherence assessed using a 
validated tool. The results showed that for the intervention group, which received 
pharmaceutical care services, there was a significant decline in systolic and diastolic 
blood pressure and improved medication adherence from baseline, in comparison 
to the control group. CONCLUSIONS: Pharmaceutical care may improve adherence 
and blood pressure control in hypertensive individuals. The evidence supports the 
wider provision of pharmaceutical care for hypertension management in various 
practice settings.
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OBJECTIVES: Mental illness is a global public health concern with clinical and 
economical burden. Medication non-adherence increases the risk outcomes (e.g. 
relapse, re-hospitalization and delayed illness recovery) of mental health care. The 
purpose of this study was to determine the effects (positive, negative or none) of 
social networks on patient adherence to prescribed treatment for serious mental ill-
ness (SMI). METHODS: We systematically reviewed studies published from January 
2003 to December 2012. We evaluated five established social network interventions 
(education and behavioral support, social support, collaborative care; case man-
agement, care management) with three outcomes (improved patient adherence 
to prescribed mental health treatment protocol, hindered/impeded patient adher-
ence to prescribed mental health treatment protocol & no effect on patient adher-
ence to prescribed mental health treatment protocol). We assessed the number of 
studies that reported improved, hindered or no effect outcome by summarizing 
the studies and listing their main outcomes. We also assessed the quality of the 
studies by checking yes (or no) whether they met methodological quality criteria, 
and assigned a percentage score that indicated the strength of quality. Quality 
was based on reporting and design standards and statistical soundness. RESULTS: 
Thirteen studies met the inclusion criteria of enrolling patients suffering from SMI 
and reporting effects of social network relating to patient adherence to prescribed 
mental healthcare treatment. Nine studies reported improved, three reported no 
effect and only one reported hindered outcome. All studies met the general quality 
criteria but their strength varied. CONCLUSIONS: The findings indicate that social 
networks improved patient adherence to prescribed mental illness treatment but 
there are limitations to these findings. The potential for publication bias under-
scores the need to more closely examine the results of evidence-based research.
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OBJECTIVES: To assess the factors associated with high allopurinol adher-
ence. METHODS: Allopurinol prescription was defined as at least 30 days of a 
filled allopurinol prescription. Patients were censored when they switched from 
allopurinol to one of the other ULT. Index allopurinol prescription was defined 
